News

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...
The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...
The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or ...
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs. In his book, he compares the ...
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
A government crackdown on cheaper copies of Ozempic and similar diabetes and weight ... dosages slightly different from the standard, FDA-approved amounts or including additives such as vitamins ...